ArticleDiscover nano2024
Ocimum basilicum seed-mediated green synthesis of silver nanoparticles: characterization and evaluation of biological properties.
Article in Discover nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antimicrobial, antibiofilm, and molecular docking evaluation of silver nanoparticles biosynthesized from Ocimum campechianum against Staphylococcus spp.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
- Thymoquinone loaded zinc oxide Nanoformulations synthesis, characterization and evaluation of their efficacy against carbon tetrachloride induced Hepatorenal toxicity in rats.Toxicology research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanoparticles synthesized from green sources have attracted great recognition in the present times, which can be ascribed to their distinctive attributes and diversified applicability. Therefore, the present study employed Ocimum basilicum seed extract to synthesize silver nanoparticles. UV-vis spectrophotometry revealed strenuous peaks for different concentrations of silver nanoparticles ranging between 400 and 430 nm. The average crystal size calculated using X-ray diffraction analysis was 6.7 nm. Energy-dispersive X-ray analysis clearly displayed the presence of silver ions in the elemental structure of the synthesized nanoparticles. The morphology of synthesized nanoparticles revealed by scanning electron microscopy was documented in terms of spherical shape surrounded by an organic layer and nanoparticle size was estimated to be in between 10 and 80 nm. The nanoparticles exhibited substantial antibacterial activity against 46 foodborne bacterial isolates and 15 clinical isolates of Klebsiella pneumoniae, with the largest inhibition zones measuring 24 and 13 mm, respectively. Minimum inhibitory concentration values ranged between 500 and 800 µl/ml for various isolates. The antibacterial effect of all antibiotics revealed considerable enhancement when combined with nanoparticles. The calculated fractional inhibitory concentration index values were < 1 validating excellent synergism between nanoparticles and all antibiotics except ciprofloxacin against the majority of bacterial isolates. Interestingly, the biogenic nanoparticles showed significant antioxidant potential with IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.